A signature of differential gene expression in bronchoalveolar lavage fluid predicts mortality in influenza-associated pulmonary aspergillosis

Intensive Care Med. 2023 Feb;49(2):254-257. doi: 10.1007/s00134-022-06958-w. Epub 2023 Jan 2.

Authors

Simon Feys^{1

2}, Jannes Heylen^{3

4}, Agostinho Carvalho^{5

6}, Johan Van Weyenbergh⁷, Joost Wauters^{8

9}; Variomic Study Group

Affiliations

¹ Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium. [email protected].
² Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium. [email protected].
³ Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium.
⁴ Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium.
⁵ Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
⁶ ICVS/3B's-PT Government Associate Laboratory, Braga/Guimarães, Portugal.
⁷ Department of Microbiology, Immunology and Transplantation, Rega Institute, KU Leuven, Leuven, Belgium.
⁸ Medical Intensive Care Unit, University Hospitals Leuven, Leuven, Belgium. [email protected].
⁹ Department of Microbiology, Immunology and Transplantation, KU Leuven, Leuven, Belgium. [email protected].

No abstract available

Publication types

Letter

MeSH terms

Bronchoalveolar Lavage
Bronchoalveolar Lavage Fluid
Gene Expression
Humans
Influenza, Human*
Invasive Pulmonary Aspergillosis*
Mannans
Pulmonary Aspergillosis*
Sensitivity and Specificity

Substances

Mannans

Grants and funding